Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now early-phase tilt small index

Chronic Myeloid Leukemia, BCR-ABL1 Positive: early-phase trial registry

4 of 5 indexed Chronic Myeloid Leukemia, BCR-ABL1 Positive trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

5 US clinical trials · 4 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Chronic Myeloid Leukemia, BCR-ABL1 Positive: 5 US clinical trials tracked, 4 recruiting.

Chronic Myeloid Leukemia, BCR-ABL1 Positive is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Fred Hutchinson Cancer Center, running 2 of these trials.

Enrollment posture brief

Registry condition chronic-myeloid-leukemia-bcr-abl1-positive

OPEN 4 | RECR 80% | LATE 0 | EARLY 5 | RANK #3391 | SPON 2

Volume-matched condition peers

Nearest open-share peer: Acute Leukemia of Ambiguous Lineage (80% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Chronic Myeloid Leukemia (th…80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Chronic Myeloid Leukemia, BCR-ABL1 Positive

Chronic Myeloid Leukemia, BCR-ABL1 Positive lists 4 open slots (80% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Chronic Myeloid Leukemia, BCR-ABL1 Positive on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Chronic Myeloid Leukemia, BCR-ABL1 Positive is recruiting above its size-band peers.

    4 of 5 indexed trials (80%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Chronic Myeloid Leukemia, BCR-ABL1 Positive research.

    Fred Hutchinson Cancer Center accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Chronic Myeloid Leukemia, BCR-ABL1 Positive trials plan to enrol fewer than 100 people.

    Median target enrolment is 63 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Chronic Myeloid Leukemia, BCR-ABL1 Positive research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 25

Phase Distribution

PhaseTrial count
Phase 2 5

Top Sponsors

Fred Hutchinson Cancer Center 2 trials
City of Hope Medical Center 1 trials
Thomas Jefferson University 1 trials
National Cancer Institute (NCI) 1 trials

Named interventions

Most-linked intervention names on Chronic Myeloid Leukemia, BCR-ABL1 Positive records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Cyclophosphamide Drug
3 trials
Allogeneic Hematopoietic Stem Cell Transplantation Procedure
2 trials
Cyclosporine Drug
2 trials
Biospecimen Collection Procedure
2 trials
Fludarabine Drug
2 trials
Imatinib Mesylate Drug
1 trials
Hematopoietic Cell Transplantation Conditioning Regimen Drug
1 trials
Granulocyte Colony-Stimulating Factor Drug
1 trials

US sites by state

Facility locations filed on Chronic Myeloid Leukemia, BCR-ABL1 Positive trials. A trial with sites in several states counts in each.

Washington 2 trials
California 2 trials
Pennsylvania 1 trials
Massachusetts 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Chronic Myeloid Leukemia, BCR-ABL1 Positive page

5 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 4 Chronic Myeloid Leukemia, BCR-ABL1 Positive trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Fred Hutchinson Cancer Center sponsors the most Chronic Myeloid Leukemia, BCR-ABL1 Positive trials on record, review their full trial history before evaluating a specific study. See Fred Hutchinson Cancer Center's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Myeloid Leukemia, BCR-ABL1 Positive condition card totals 5 registered trials; most-linked intervention Cyclophosphamide; top US site state Washington. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.